Amber A. Rivera

Synthesis and evaluation of tetrahydropyrazolopyridine inhibitors of anion exchange protein SLC26A4 (pendrin).

A. Verkman, J. Son, P. Haggie, 2019, Bioorganic & medicinal chemistry letters.

Repurposing calcium-sensing receptor agonist cinacalcet for treatment of CFTR-mediated secretory diarrheas

A. Verkman, O. Cil, Amber A. Rivera, 2021, JCI insight.

SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine

A. Verkman, P. Haggie, Joseph-Anthony Tan, 2021, JCI insight.

SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation.

A. Verkman, P. Haggie, Sujin Lee, 2018, JCI insight.

Nanomolar-potency ‘co-potentiator’ therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants

A. Verkman, W. Finkbeiner, P. Haggie, 2019, Scientific Reports.

CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation.

A. Verkman, W. Finkbeiner, P. Haggie, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.